SF-1을 매개한 CYP19의 전사활성에 미치는 FOXL2 야생형과 돌연변이형의 차별적 영향
Differential Activities of FOXL2 and Its Mutants on SF-1-Induced CYP19 Transcriptional Activation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
FOXL2 is a winged-helix/forkhead (FH) domain transcription factor, and mutations in FOXL2 gene are responsible for blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). BPES is an autosomal dominant genetic disease. BPES type I patients exhibit both premature ovarian failure (POF) and eyelid malformation, while only the eyelid defect is observed in BPES type II. FOXL2-null ovaries showed a blockage of granulosa cell differentiation, suggesting that FOXL2 plays an essential role for proper ovarian folliculogenesis. Previously, we screened for FOXL2-interacting proteins and identified steroidogenic factor-1 (SF-1) which is known to be required for gonad development and transactivates steroidogenic enzymes including CYP19. In the present study, we demonstrated that FOXL2 transactivates CYP19 and stimulated the transcriptional activation of CYP19 induced by SF-1. In contrast, FOXL2 mutants found in BPES type I and II exhibited compromised abilities to enhance CYP19 induction mediated by SF-1. Thus, this study provides a functional difference between wild-type FOXL2 and its mutants which may aid to understand pathophysiology of BPES elicited by FOXL2 mutations.
Abstract
FOXL2 is a winged-helix/forkhead (FH) domain transcription factor, and mutations in FOXL2 gene are responsible for blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). BPES is an autosomal dominant genetic disease. BPES type I patients exhibit both premature ovarian failure (POF) and eyelid malformation, while only the eyelid defect is observed in BPES type II. FOXL2-null ovaries showed a blockage of granulosa cell differentiation, suggesting that FOXL2 plays an essential role for proper ovarian folliculogenesis. Previously, we screened for FOXL2-interacting proteins and identified steroidogenic factor-1 (SF-1) which is known to be required for gonad development and transactivates steroidogenic enzymes including CYP19. In the present study, we demonstrated that FOXL2 transactivates CYP19 and stimulated the transcriptional activation of CYP19 induced by SF-1. In contrast, FOXL2 mutants found in BPES type I and II exhibited compromised abilities to enhance CYP19 induction mediated by SF-1. Thus, this study provides a functional difference between wild-type FOXL2 and its mutants which may aid to understand pathophysiology of BPES elicited by FOXL2 mutations.
참고문헌 (28)
- Beysen D, "The human FOXL2 mutation database", Hum Mutat, 24, pp.189~193 (2004)
- Crisponi L, "The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis", ptosis, Nat Genet, pp.2001, 27[DOI]
- De Baere E, "FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation", Am J Hum Genet, 72, pp.478~487 (2003)
- de Moraes-Ruehsen M, "Premature ovarian failure", Fertil Steril, 18, pp.440~461 (1967)
- Falender AE, "Differential expression of steroidogenic factor-1 and FTF", LRH-1 in the rodent ovary, 2003, pp.144, 3598~3610
- Gurates B, "WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells", Mol Cell Endocrinol, 208, pp.61~75 (2003)
- Hanley NA, "Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation", Mol Endocrinol, 15, pp.57~68 (2001)
- Hoek A, "Premature ovarian failure and ovarian autoimmunity", Endocr Rev, 18, pp.107~134 (1997)
- Jagarlamudi K, "Oocyte-specific deletion of Pten in mice reveals a stage-specific function of PTEN", PI3K signaling in oocytes in controlling follicular activation, 2009, pp.4, e6186~
- J Cocquet, , ~
- C Cotinot, "Evolution and expression of FOXL2", J Med Genet, 39, pp.916~922 (2002)
- Jeyasuria P, "Cell- specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function", Mol Endocrinol, 18, pp.1610~1619 (2004)
- Leers-Sucheta S, "Synergistic activation of the human type II 3beta-hydroxysteroid dehydrogenase", delta5-delta4 isomerase promoter by the transcription factor steroidogenic factor-1, J Biol Chem, pp.1997, 272[DOI]
- Luo X, "A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation", Cell, 77, pp.481~490 (1994)
- Matzuk MM, "Genetic dissection of mammalian fertility pathways", Nat Cell Biol, pp.s41~s49 (2002)
- Michael MD, "Ad4BP", SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary, 1995, pp.270, 13561~13566
- Pannetier M, "FOXL2 activates P450 aromatase gene transcription: towards abetter characterization of the early steps of mammalian ovarian development", J Mol Endocrinol, 36, pp.399~413 (2006)
- Park M, "FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells", Mol Endocrinol, 24, pp.1024~1036 (2010)
- Parker KL, "Steroidogenic factor 1: an essential mediator of endocrine development", Recent Prog Horm Res, 57, pp.19~36 (2002)
- Pisarska MD, "Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene", Endocrinology, 145, pp.3424~3433 (2004)
- Schmidt D, "The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance", Development, 131, pp.933~942 (2004)
- Shapiro DB, "Steroidogenic factor-1 as a positive regulator of rat granulosa cell differentiation and a negative regulator of mitosis", Endocrinology, 137, pp.1187~1195 (1996)
- Simpson JL, "Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes", Ann N Y Acad Sci, 1135, pp.146~154 (2008)
- Sugawara T, "Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene", Biochemistry, 35, pp.9052~9059 (1996)
- Uda M, "Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development", Hum Mol Genet, 13, pp.1171~1181 (2004)
- Uhlenhaut NH, "Foxl2 function in ovarian development", Mol Genet Metab, 88, pp.225~234 (2006)
- Zhou LY, "Characterization, expression and transcriptional regulation of P450c17-I and -II in the medaka, Oryzias latipes", Biochem Biophys Res Commun, 362, pp.619~625 (2007)
- 김정욱, "조기 난소 부전증(Premature Ovarian Failure, POF) 환자에서 난포 자극 호르몬 수용체 유전자 변이 및 발현 양상에 대한 분석", 발생과 생식, 4, pp.61~66 (2000)